SrasV1, Istex, Corpus, bibRecord, 000B60

Pandemic influenza A (H1N1) 2009: the experience of the first six months

Identifieur interne : 000B60 ( Istex/Corpus ); précédent : 000B59; suivant : 000B61

Pandemic influenza A (H1N1) 2009: the experience of the first six months

Auteurs : Jean Maritz ; Leana Maree ; Wolfgang Preiser

Source :

Clinical Chemistry and Laboratory Medicine [ 1434-6621 ] ; 2010.

RBID : ISTEX:D1BE8AC6F37BA8FCD15A07D02D0AF71100528FB1

English descriptors

Teeft :
- Alveolar damage, Animal models, Antiviral, Antiviral medications, Antiviral therapy, Briefing note, Cape town, Case fatality rate, Case series, Chest radiograph, Chronic lung disease, Clin virol centers, Clinical aspects, Clinical diagnosis, Clinical presentations, Comorbid conditions, Current pandemic, Disease control, Distress syndrome, Engl, Euro, Euro surveill, European medicines agency, Fatal cases, Fatality, First influenza pandemic, Gastrointestinal symptoms, General population, Health care workers, Health services, High dose treatment, Higher risk, Hospital admission, Hospital admissions, Hospitalisation, Hospitalisation rates, Hospitalised, Hospitalised patients, Household contacts, Human beings, Infection, Influenza, Influenza infection, Influenza pandemic, Influenza season, Influenza virus, Influenza viruses, Inhibitor, Intensive care, Interim recommendations, Invasive ventilation, Laboratory testing, Large clusters, Leana maree, Maritz, Median, Medical condition, Medical virology, Mmwr, Mmwr http, Monovalent vaccines, Morbidity, Mortality rates, National health laboratory service, Neuraminidase, Neuraminidase inhibitors, Northern hemisphere, Novel influenza, Oseltamivir, Oseltamivir prophylaxis, Oseltamivir resistance, Outbreak, Pandemic, Pandemic infection, Pandemic influenza, Pandemic strain, Pandemic strains, Pandemic virus, Pandemic virus infection, Pregnant females, Pregnant patients, Pregnant women, Previous influenza pandemics, Previous pandemics, Probable infection, Proof maritz, Prophylaxis, Pulmonary disease, Rapid antigen tests, Rapid influenza, Reproductive number, Respiratory droplets, Respiratory failure, Respiratory symptoms, Risk factors, Seasonal influenza, Seasonal influenza epidemics, Seasonal influenza vaccine, Secondary attack rate, Severe cases, Severe disease, Single dose, Southern hemisphere, Streptococcus pneumoniae, Subtype influenza, Surveill, Swine, Swine herds, Swine influenza virus, Swine origin, Third trimester, Total number, Trimester, Vaccine, Viral, Viral culture, Virus, Virus infection, Virus subtypes, Wide range, World health organization, Young adults, Young children, Young patients, Zealand.

Abstract

After a break of 41 years, 2009 saw the first influenza pandemic of the 21st century caused by a triple-reassortant influenza A (H1N1) virus. The current estimated case fatality rate is lower than that of previous influenza pandemics, but this may change as the pandemic evolves. Illness frequently occurs in previously healthy, young adults with a wide range of clinical presentations. The majority of circulating pandemic viruses remain susceptible to neuraminidase inhibitors, although all strains are intrinsically resistant to the adamantanes. Monovalent vaccines against the pandemic strain are available in both live attenuated and inactivated forms. This review aims to summarise important virological, epidemiological and clinical aspects of the pandemic influenza A (H1N1) virus for physicians and other clinical personnel. Clin Chem Lab Med 2010;48:11–21.

Url:

https://api.istex.fr/ark:/67375/QT4-JJXDM453-F/fulltext.pdf

DOI: 10.1515/CCLM.2010.023

Links to Exploration step

ISTEX:D1BE8AC6F37BA8FCD15A07D02D0AF71100528FB1

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pandemic influenza A (H1N1) 2009: the experience of the first six months</title>
<author><name sortKey="Maritz, Jean" sort="Maritz, Jean" uniqKey="Maritz J" first="Jean" last="Maritz">Jean Maritz</name>
<affiliation><mods:affiliation>Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town, South Africa</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Maree, Leana" sort="Maree, Leana" uniqKey="Maree L" first="Leana" last="Maree">Leana Maree</name>
<affiliation><mods:affiliation>Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town, South Africa</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Preiser, Wolfgang" sort="Preiser, Wolfgang" uniqKey="Preiser W" first="Wolfgang" last="Preiser">Wolfgang Preiser</name>
<affiliation><mods:affiliation>Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town, South Africa</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D1BE8AC6F37BA8FCD15A07D02D0AF71100528FB1</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1515/CCLM.2010.023</idno>
<idno type="url">https://api.istex.fr/ark:/67375/QT4-JJXDM453-F/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000B60</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B60</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Pandemic influenza A (H1N1) 2009: the experience of the first six months</title>
<author><name sortKey="Maritz, Jean" sort="Maritz, Jean" uniqKey="Maritz J" first="Jean" last="Maritz">Jean Maritz</name>
<affiliation><mods:affiliation>Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town, South Africa</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Maree, Leana" sort="Maree, Leana" uniqKey="Maree L" first="Leana" last="Maree">Leana Maree</name>
<affiliation><mods:affiliation>Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town, South Africa</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Preiser, Wolfgang" sort="Preiser, Wolfgang" uniqKey="Preiser W" first="Wolfgang" last="Preiser">Wolfgang Preiser</name>
<affiliation><mods:affiliation>Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town, South Africa</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="abbrev">Clinical Chemistry and Laboratory Medicine</title>
<idno type="eISSN">1437-4331</idno>
<idno type="ISSN">1434-6621</idno>
<imprint><publisher>Walter de Gruyter</publisher>
<date type="published">2010</date>
<date type="e-published">2009</date>
<biblScope unit="vol">48</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="11">11</biblScope>
<biblScope unit="page" to="21">21</biblScope>
<biblScope unit="ref-count">79</biblScope>
<biblScope unit="fig-count">2</biblScope>
<biblScope unit="table-count">1</biblScope>
</imprint>
<idno type="ISSN">1434-6621</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1434-6621</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Alveolar damage</term>
<term>Animal models</term>
<term>Antiviral</term>
<term>Antiviral medications</term>
<term>Antiviral therapy</term>
<term>Briefing note</term>
<term>Cape town</term>
<term>Case fatality rate</term>
<term>Case series</term>
<term>Chest radiograph</term>
<term>Chronic lung disease</term>
<term>Clin virol centers</term>
<term>Clinical aspects</term>
<term>Clinical diagnosis</term>
<term>Clinical presentations</term>
<term>Comorbid conditions</term>
<term>Current pandemic</term>
<term>Disease control</term>
<term>Distress syndrome</term>
<term>Engl</term>
<term>Euro</term>
<term>Euro surveill</term>
<term>European medicines agency</term>
<term>Fatal cases</term>
<term>Fatality</term>
<term>First influenza pandemic</term>
<term>Gastrointestinal symptoms</term>
<term>General population</term>
<term>Health care workers</term>
<term>Health services</term>
<term>High dose treatment</term>
<term>Higher risk</term>
<term>Hospital admission</term>
<term>Hospital admissions</term>
<term>Hospitalisation</term>
<term>Hospitalisation rates</term>
<term>Hospitalised</term>
<term>Hospitalised patients</term>
<term>Household contacts</term>
<term>Human beings</term>
<term>Infection</term>
<term>Influenza</term>
<term>Influenza infection</term>
<term>Influenza pandemic</term>
<term>Influenza season</term>
<term>Influenza virus</term>
<term>Influenza viruses</term>
<term>Inhibitor</term>
<term>Intensive care</term>
<term>Interim recommendations</term>
<term>Invasive ventilation</term>
<term>Laboratory testing</term>
<term>Large clusters</term>
<term>Leana maree</term>
<term>Maritz</term>
<term>Median</term>
<term>Medical condition</term>
<term>Medical virology</term>
<term>Mmwr</term>
<term>Mmwr http</term>
<term>Monovalent vaccines</term>
<term>Morbidity</term>
<term>Mortality rates</term>
<term>National health laboratory service</term>
<term>Neuraminidase</term>
<term>Neuraminidase inhibitors</term>
<term>Northern hemisphere</term>
<term>Novel influenza</term>
<term>Oseltamivir</term>
<term>Oseltamivir prophylaxis</term>
<term>Oseltamivir resistance</term>
<term>Outbreak</term>
<term>Pandemic</term>
<term>Pandemic infection</term>
<term>Pandemic influenza</term>
<term>Pandemic strain</term>
<term>Pandemic strains</term>
<term>Pandemic virus</term>
<term>Pandemic virus infection</term>
<term>Pregnant females</term>
<term>Pregnant patients</term>
<term>Pregnant women</term>
<term>Previous influenza pandemics</term>
<term>Previous pandemics</term>
<term>Probable infection</term>
<term>Proof maritz</term>
<term>Prophylaxis</term>
<term>Pulmonary disease</term>
<term>Rapid antigen tests</term>
<term>Rapid influenza</term>
<term>Reproductive number</term>
<term>Respiratory droplets</term>
<term>Respiratory failure</term>
<term>Respiratory symptoms</term>
<term>Risk factors</term>
<term>Seasonal influenza</term>
<term>Seasonal influenza epidemics</term>
<term>Seasonal influenza vaccine</term>
<term>Secondary attack rate</term>
<term>Severe cases</term>
<term>Severe disease</term>
<term>Single dose</term>
<term>Southern hemisphere</term>
<term>Streptococcus pneumoniae</term>
<term>Subtype influenza</term>
<term>Surveill</term>
<term>Swine</term>
<term>Swine herds</term>
<term>Swine influenza virus</term>
<term>Swine origin</term>
<term>Third trimester</term>
<term>Total number</term>
<term>Trimester</term>
<term>Vaccine</term>
<term>Viral</term>
<term>Viral culture</term>
<term>Virus</term>
<term>Virus infection</term>
<term>Virus subtypes</term>
<term>Wide range</term>
<term>World health organization</term>
<term>Young adults</term>
<term>Young children</term>
<term>Young patients</term>
<term>Zealand</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">After a break of 41 years, 2009 saw the first influenza pandemic of the 21st century caused by a triple-reassortant influenza A (H1N1) virus. The current estimated case fatality rate is lower than that of previous influenza pandemics, but this may change as the pandemic evolves. Illness frequently occurs in previously healthy, young adults with a wide range of clinical presentations. The majority of circulating pandemic viruses remain susceptible to neuraminidase inhibitors, although all strains are intrinsically resistant to the adamantanes. Monovalent vaccines against the pandemic strain are available in both live attenuated and inactivated forms. This review aims to summarise important virological, epidemiological and clinical aspects of the pandemic influenza A (H1N1) virus for physicians and other clinical personnel. Clin Chem Lab Med 2010;48:11–21.</div>
</front>
</TEI>
<istex><corpusName>degruyter-journals</corpusName>
<keywords><teeft><json:string>influenza</json:string>
<json:string>pandemic</json:string>
<json:string>oseltamivir</json:string>
<json:string>pandemic influenza</json:string>
<json:string>antiviral</json:string>
<json:string>disease control</json:string>
<json:string>vaccine</json:string>
<json:string>maritz</json:string>
<json:string>world health organization</json:string>
<json:string>neuraminidase</json:string>
<json:string>pandemic virus</json:string>
<json:string>mmwr</json:string>
<json:string>engl</json:string>
<json:string>hospitalised</json:string>
<json:string>hospitalised patients</json:string>
<json:string>euro surveill</json:string>
<json:string>viral</json:string>
<json:string>seasonal influenza</json:string>
<json:string>euro</json:string>
<json:string>surveill</json:string>
<json:string>hospitalisation</json:string>
<json:string>novel influenza</json:string>
<json:string>pregnant women</json:string>
<json:string>morbidity</json:string>
<json:string>pregnant patients</json:string>
<json:string>rapid antigen tests</json:string>
<json:string>prophylaxis</json:string>
<json:string>pandemic infection</json:string>
<json:string>pandemic strain</json:string>
<json:string>neuraminidase inhibitors</json:string>
<json:string>southern hemisphere</json:string>
<json:string>median</json:string>
<json:string>influenza viruses</json:string>
<json:string>proof maritz</json:string>
<json:string>current pandemic</json:string>
<json:string>influenza virus</json:string>
<json:string>antiviral therapy</json:string>
<json:string>fatality</json:string>
<json:string>intensive care</json:string>
<json:string>severe cases</json:string>
<json:string>higher risk</json:string>
<json:string>influenza pandemic</json:string>
<json:string>influenza infection</json:string>
<json:string>third trimester</json:string>
<json:string>pandemic virus infection</json:string>
<json:string>general population</json:string>
<json:string>trimester</json:string>
<json:string>virus</json:string>
<json:string>oseltamivir resistance</json:string>
<json:string>pregnant females</json:string>
<json:string>hospital admissions</json:string>
<json:string>fatal cases</json:string>
<json:string>pandemic strains</json:string>
<json:string>viral culture</json:string>
<json:string>secondary attack rate</json:string>
<json:string>subtype influenza</json:string>
<json:string>influenza season</json:string>
<json:string>respiratory failure</json:string>
<json:string>seasonal influenza vaccine</json:string>
<json:string>young adults</json:string>
<json:string>monovalent vaccines</json:string>
<json:string>hospital admission</json:string>
<json:string>infection</json:string>
<json:string>swine</json:string>
<json:string>inhibitor</json:string>
<json:string>outbreak</json:string>
<json:string>case fatality rate</json:string>
<json:string>streptococcus pneumoniae</json:string>
<json:string>clinical diagnosis</json:string>
<json:string>total number</json:string>
<json:string>hospitalisation rates</json:string>
<json:string>northern hemisphere</json:string>
<json:string>pulmonary disease</json:string>
<json:string>medical condition</json:string>
<json:string>chest radiograph</json:string>
<json:string>clinical aspects</json:string>
<json:string>previous influenza pandemics</json:string>
<json:string>invasive ventilation</json:string>
<json:string>virus subtypes</json:string>
<json:string>risk factors</json:string>
<json:string>human beings</json:string>
<json:string>swine herds</json:string>
<json:string>comorbid conditions</json:string>
<json:string>severe disease</json:string>
<json:string>young children</json:string>
<json:string>chronic lung disease</json:string>
<json:string>previous pandemics</json:string>
<json:string>animal models</json:string>
<json:string>medical virology</json:string>
<json:string>respiratory droplets</json:string>
<json:string>wide range</json:string>
<json:string>case series</json:string>
<json:string>alveolar damage</json:string>
<json:string>clinical presentations</json:string>
<json:string>reproductive number</json:string>
<json:string>health care workers</json:string>
<json:string>mortality rates</json:string>
<json:string>seasonal influenza epidemics</json:string>
<json:string>swine origin</json:string>
<json:string>virus infection</json:string>
<json:string>antiviral medications</json:string>
<json:string>health services</json:string>
<json:string>laboratory testing</json:string>
<json:string>large clusters</json:string>
<json:string>national health laboratory service</json:string>
<json:string>household contacts</json:string>
<json:string>rapid influenza</json:string>
<json:string>high dose treatment</json:string>
<json:string>single dose</json:string>
<json:string>cape town</json:string>
<json:string>oseltamivir prophylaxis</json:string>
<json:string>european medicines agency</json:string>
<json:string>swine influenza virus</json:string>
<json:string>first influenza pandemic</json:string>
<json:string>briefing note</json:string>
<json:string>interim recommendations</json:string>
<json:string>distress syndrome</json:string>
<json:string>young patients</json:string>
<json:string>respiratory symptoms</json:string>
<json:string>gastrointestinal symptoms</json:string>
<json:string>leana maree</json:string>
<json:string>mmwr http</json:string>
<json:string>clin virol centers</json:string>
<json:string>probable infection</json:string>
<json:string>zealand</json:string>
</teeft>
</keywords>
<author><json:item><name>Jean Maritz</name>
<affiliations><json:string>Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town, South Africa</json:string>
</affiliations>
</json:item>
<json:item><name>Leana Maree</name>
<affiliations><json:string>Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town, South Africa</json:string>
</affiliations>
</json:item>
<json:item><name>Wolfgang Preiser</name>
<affiliations><json:string>Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town, South Africa</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>H1N1</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>influenza A virus</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>pandemic</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>review</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>swine flu</value>
</json:item>
</subject>
<articleId><json:string>cclm.2010.023</json:string>
</articleId>
<arkIstex>ark:/67375/QT4-JJXDM453-F</arkIstex>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>review-article</json:string>
</originalGenre>
<abstract>After a break of 41 years, 2009 saw the first influenza pandemic of the 21st century caused by a triple-reassortant influenza A (H1N1) virus. The current estimated case fatality rate is lower than that of previous influenza pandemics, but this may change as the pandemic evolves. Illness frequently occurs in previously healthy, young adults with a wide range of clinical presentations. The majority of circulating pandemic viruses remain susceptible to neuraminidase inhibitors, although all strains are intrinsically resistant to the adamantanes. Monovalent vaccines against the pandemic strain are available in both live attenuated and inactivated forms. This review aims to summarise important virological, epidemiological and clinical aspects of the pandemic influenza A (H1N1) virus for physicians and other clinical personnel. Clin Chem Lab Med 2010;48:11–21.</abstract>
<qualityIndicators><score>6.5</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>595 x 794 pts</pdfPageSize>
<refBibsNative>false</refBibsNative>
<keywordCount>5</keywordCount>
<abstractCharCount>866</abstractCharCount>
<pdfWordCount>7627</pdfWordCount>
<pdfWordsPerPage>693</pdfWordsPerPage>
<pdfCharCount>49647</pdfCharCount>
<pdfPageCount>11</pdfPageCount>
<abstractWordCount>125</abstractWordCount>
<pdfText>true</pdfText>
</qualityIndicators>
<title>Pandemic influenza A (H1N1) 2009: the experience of the first six months</title>
<pmid><json:string>20025556</json:string>
</pmid>
<genre><json:string>review-article</json:string>
</genre>
<host><title>Clinical Chemistry and Laboratory Medicine</title>
<language><json:string>unknown</json:string>
</language>
<publicationDate>2010</publicationDate>
<copyrightDate>2010</copyrightDate>
<issn><json:string>1434-6621</json:string>
</issn>
<eissn><json:string>1437-4331</json:string>
</eissn>
<publisherId><json:string>cclm</json:string>
</publisherId>
<volume>48</volume>
<issue>1</issue>
<pages><first>11</first>
<last>21</last>
</pages>
<genre><json:string>journal</json:string>
</genre>
</host>
<namedEntities><unitex><date><json:string>2009</json:string>
<json:string>the 21st century</json:string>
<json:string>1930</json:string>
<json:string>1957</json:string>
<json:string>1918</json:string>
<json:string>2009-12-22</json:string>
<json:string>2007</json:string>
<json:string>1950</json:string>
<json:string>2003</json:string>
<json:string>2008</json:string>
<json:string>during the 20th century</json:string>
</date>
<geogName></geogName>
<orgName><json:string>New Zealand and South</json:string>
<json:string>WHO</json:string>
<json:string>Mexico and the USA</json:string>
<json:string>EMEA</json:string>
<json:string>South Africa Phone</json:string>
<json:string>In Australia and New Zealand</json:string>
<json:string>Department of Pathology, National Health Laboratory Service and University</json:string>
<json:string>New Zealand and Australia</json:string>
<json:string>South Africa Abstract After</json:string>
<json:string>Acknowledgements South African National Institute of Communicable Diseases</json:string>
<json:string>Division of Medical Virology</json:string>
<json:string>European Medicines Agency</json:string>
<json:string>World Health Organization</json:string>
</orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName><json:string>Studies</json:string>
<json:string>Leana Maree</json:string>
<json:string>Australia</json:string>
<json:string>Mexico</json:string>
<json:string>Africa</json:string>
<json:string>Zealand</json:string>
<json:string>Jean Maritz</json:string>
<json:string>Wolfgang Preiser</json:string>
</persName>
<placeName><json:string>Australia</json:string>
<json:string>American</json:string>
<json:string>Cape Province</json:string>
<json:string>China</json:string>
<json:string>Europe</json:string>
<json:string>Japan</json:string>
<json:string>America</json:string>
<json:string>Wales</json:string>
<json:string>South Africa</json:string>
<json:string>New Zealand</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl><json:string>July 2009</json:string>
<json:string>Maritz et al.</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark><json:string>ark:/67375/QT4-JJXDM453-F</json:string>
</ark>
<categories><wos><json:string>1 - science</json:string>
<json:string>2 - medical laboratory technology</json:string>
</wos>
<scienceMetrix><json:string>1 - health sciences</json:string>
<json:string>2 - clinical medicine</json:string>
<json:string>3 - general clinical medicine</json:string>
</scienceMetrix>
<scopus><json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Biochemistry, medical</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Clinical Biochemistry</json:string>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - General Medicine</json:string>
</scopus>
<inist><json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences medicales</json:string>
</inist>
</categories>
<publicationDate>2010</publicationDate>
<copyrightDate>2010</copyrightDate>
<doi><json:string>10.1515/CCLM.2010.023</json:string>
</doi>
<id>D1BE8AC6F37BA8FCD15A07D02D0AF71100528FB1</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/QT4-JJXDM453-F/fulltext.pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/QT4-JJXDM453-F/bundle.zip</uri>
</json:item>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/QT4-JJXDM453-F/fulltext.txt</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/QT4-JJXDM453-F/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Pandemic influenza A (H1N1) 2009: the experience of the first six months</title>
<respStmt><resp>Références bibliographiques récupérées via GROBID</resp>
<name resp="ISTEX-API">ISTEX-API (INIST-CNRS)</name>
</respStmt>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Walter de Gruyter</publisher>
<availability><licence>©2010 by Walter de Gruyter Berlin New York</licence>
</availability>
<date type="e-published">2009</date>
<date type="Copyright" when="2010">2010</date>
</publicationStmt>
<notesStmt><note type="content-type" source="review-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note>
<note type="publication-type" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Pandemic influenza A (H1N1) 2009: the experience of the first six months</title>
<author xml:id="author-0000"><persName><surname>Maritz</surname>
<forename type="first">Jean</forename>
</persName>
<affiliation><orgName type="department">Division of Medical Virology</orgName>
<orgName type="department">Department of Pathology</orgName>
<orgName type="institution">National Health Laboratory Service and University of Stellenbosch</orgName>
<address><addrLine>Cape Town</addrLine>
<country key="ZA" xml:lang="en">SOUTH AFRICA</country>
</address>
</affiliation>
</author>
<author xml:id="author-0001"><persName><surname>Maree</surname>
<forename type="first">Leana</forename>
</persName>
<affiliation><orgName type="department">Division of Medical Virology</orgName>
<orgName type="department">Department of Pathology</orgName>
<orgName type="institution">National Health Laboratory Service and University of Stellenbosch</orgName>
<address><addrLine>Cape Town</addrLine>
<country key="ZA" xml:lang="en">SOUTH AFRICA</country>
</address>
</affiliation>
</author>
<author xml:id="author-0002"><persName><surname>Preiser</surname>
<forename type="first">Wolfgang</forename>
</persName>
<affiliation><orgName type="department">Division of Medical Virology</orgName>
<orgName type="department">Department of Pathology</orgName>
<orgName type="institution">National Health Laboratory Service and University of Stellenbosch</orgName>
<address><addrLine>Cape Town</addrLine>
<country key="ZA" xml:lang="en">SOUTH AFRICA</country>
</address>
</affiliation>
</author>
<idno type="istex">D1BE8AC6F37BA8FCD15A07D02D0AF71100528FB1</idno>
<idno type="ark">ark:/67375/QT4-JJXDM453-F</idno>
<idno type="publisher-id">cclm.2010.023</idno>
<idno type="DOI">10.1515/CCLM.2010.023</idno>
</analytic>
<monogr><title level="j" type="abbrev">Clinical Chemistry and Laboratory Medicine</title>
<idno type="publisher-id">cclm</idno>
<idno type="eISSN">1437-4331</idno>
<idno type="pISSN">1434-6621</idno>
<imprint><publisher>Walter de Gruyter</publisher>
<date type="published">2010</date>
<date type="e-published">2009</date>
<biblScope unit="vol">48</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="11">11</biblScope>
<biblScope unit="page" to="21">21</biblScope>
<biblScope unit="ref-count">79</biblScope>
<biblScope unit="fig-count">2</biblScope>
<biblScope unit="table-count">1</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef>
<appInfo><application ident="pub2tei" version="1.0.39" when="2020-03-12"><label>pub2TEI-ISTEX</label>
<desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
                        <ref target="http://www.tei-c.org/">We use TEI</ref>
</desc>
</application>
</appInfo>
</encodingDesc>
<profileDesc><abstract><head>Abstract</head>
<p>After a break of 41 years, 2009 saw the first influenza pandemic of the 21st century caused by a triple-reassortant influenza A (H1N1) virus. The current estimated case fatality rate is lower than that of previous influenza pandemics, but this may change as the pandemic evolves. Illness frequently occurs in previously healthy, young adults with a wide range of clinical presentations. The majority of circulating pandemic viruses remain susceptible to neuraminidase inhibitors, although all strains are intrinsically resistant to the adamantanes. Monovalent vaccines against the pandemic strain are available in both live attenuated and inactivated forms. This review aims to summarise important virological, epidemiological and clinical aspects of the pandemic influenza A (H1N1) virus for physicians and other clinical personnel.</p>
<p>Clin Chem Lab Med 2010;48:11–21.</p>
</abstract>
<textClass ana="subject"><keywords scheme="heading"><term>Reviews</term>
</keywords>
</textClass>
<textClass ana="keyword"><keywords><term>H1N1</term>
<term>influenza A virus</term>
<term>pandemic</term>
<term>review</term>
<term>swine flu</term>
</keywords>
</textClass>
<langUsage><language ident="EN"></language>
</langUsage>
</profileDesc>
<revisionDesc><change when="2020-03-12" who="#istex" xml:id="pub2tei">formatting</change>
<change xml:id="refBibs-istex" who="#ISTEX-API" when="2020-04-1">References added</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
</fulltext>
<metadata><istex:metadataXml wicri:clean="corpus degruyter-journals, element #text not found" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//Atypon//DTD Atypon Systems Journal Archiving and Interchange NLM DTD v3.0.2 20101108//EN" URI="atypon_archive-interchange-dtd-3.0.2/atypon-archivearticle3.dtd" name="istex:docType"></istex:docType>
<istex:document><article article-type="review-article" xml:lang="EN"><front>

<journal-meta>

<journal-id journal-id-type="publisher-id">cclm</journal-id>

<journal-title-group>

<abbrev-journal-title abbrev-type="full">Clinical Chemistry and Laboratory Medicine</abbrev-journal-title>

</journal-title-group>

<issn pub-type="epub">1437-4331</issn>

<issn pub-type="ppub">1434-6621</issn>

<publisher>

<publisher-name>Walter de Gruyter</publisher-name>

</publisher>

</journal-meta>

<article-meta>

<article-id pub-id-type="publisher-id">cclm.2010.023</article-id>

<article-id pub-id-type="doi">10.1515/CCLM.2010.023</article-id>

<article-categories>

<subj-group subj-group-type="heading">

<subject>Reviews</subject>

</subj-group>

</article-categories>

<title-group>

<article-title>Pandemic influenza A (H1N1) 2009: the experience of the first six months</article-title>

</title-group>

<contrib-group>

<contrib contrib-type="author">

<name name-style="western">

<surname>Maritz</surname>

<given-names>Jean</given-names>

</name>

<xref ref-type="aff" rid="aff1"><sup>1</sup>
</xref>
<x>, </x>

</contrib>

<contrib contrib-type="author">

<name name-style="western">

<surname>Maree</surname>

<given-names>Leana</given-names>

</name>

<xref ref-type="aff" rid="aff1"><sup>1</sup>
</xref>
<x>, </x>

</contrib>

<contrib contrib-type="author">

<name name-style="western">

<surname>Preiser</surname>

<given-names>Wolfgang</given-names>

</name>

<xref ref-type="aff" rid="aff1"><sup>1</sup>
</xref>
<x>, </x>

</contrib>

<aff id="aff1"><sup>1</sup>
Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town, South Africa</aff>

</contrib-group>

<author-notes>

<corresp>Corresponding authors: Jean Maritz, MBChB MSc and Leana Maree, MBChB, Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town 7505, South Africa Phone: +27 21 938 9347, Fax: +27 21 938 9361, <email xlink:href="mailto:jean.maritz@gmail.com">jean.maritz@gmail.com</email>
; <email xlink:href="mailto:leana@sun.ac.za">leana@sun.ac.za</email>
</corresp>

</author-notes>

<pub-date pub-type="ppub">

<day>01</day>

<month>01</month>

<year>2010</year>

<string-date>January 2010</string-date>

</pub-date>

<pub-date pub-type="epub">

<day>22</day>

<month>12</month>

<year>2009</year>

</pub-date>

<volume>48</volume>

<issue>1</issue>

<fpage>11</fpage>

<lpage>21</lpage>

<history>

<date date-type="received">

<day>21</day>

<month>11</month>

<year>2009</year>

</date>

<date date-type="accepted">

<day>23</day>

<month>11</month>

<year>2009</year>

</date>

</history>

<permissions>

<copyright-statement>©2010 by Walter de Gruyter Berlin New York</copyright-statement>

<copyright-year>2010</copyright-year>

</permissions>

<related-article related-article-type="pdf" xlink:href="cclm.2010.023.pdf"></related-article>

<abstract>

<title>Abstract</title>

<p>After a break of 41 years, 2009 saw the first influenza pandemic of the 21st century caused by a triple-reassortant influenza A (H1N1) virus. The current estimated case fatality rate is lower than that of previous influenza pandemics, but this may change as the pandemic evolves. Illness frequently occurs in previously healthy, young adults with a wide range of clinical presentations. The majority of circulating pandemic viruses remain susceptible to neuraminidase inhibitors, although all strains are intrinsically resistant to the adamantanes. Monovalent vaccines against the pandemic strain are available in both live attenuated and inactivated forms. This review aims to summarise important virological, epidemiological and clinical aspects of the pandemic influenza A (H1N1) virus for physicians and other clinical personnel.</p>

<p>Clin Chem Lab Med 2010;48:11–21.</p>

</abstract>

<kwd-group>

<title>Keywords</title>

<kwd>H1N1</kwd>
<x>, </x>

<kwd>influenza A virus</kwd>
<x>, </x>

<kwd>pandemic</kwd>
<x>, </x>

<kwd>review</kwd>
<x>, </x>

<kwd>swine flu</kwd>

</kwd-group>

<counts>

<fig-count count="2"></fig-count>

<table-count count="1"></table-count>

<ref-count count="79"></ref-count>

</counts>

</article-meta>

</front>
</article>

</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>Pandemic influenza A (H1N1) 2009: the experience of the first six months</title>
</titleInfo>
<titleInfo type="alternative" lang="en" contentType="CDATA"><title>Pandemic influenza A (H1N1) 2009: the experience of the first six months</title>
</titleInfo>
<name type="personal"><namePart type="given">Jean</namePart>
<namePart type="family">Maritz</namePart>
<affiliation>Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town, South Africa</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Leana</namePart>
<namePart type="family">Maree</namePart>
<affiliation>Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town, South Africa</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Wolfgang</namePart>
<namePart type="family">Preiser</namePart>
<affiliation>Division of Medical Virology, Department of Pathology, National Health Laboratory Service and University of Stellenbosch, Cape Town, South Africa</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="review-article" displayLabel="review-article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</genre>
<originInfo><publisher>Walter de Gruyter</publisher>
<dateIssued encoding="w3cdtf">2010-01-01</dateIssued>
<dateCreated encoding="w3cdtf">2009-12-22</dateCreated>
<copyrightDate encoding="w3cdtf">2010</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<physicalDescription><extent unit="figures">2</extent>
<extent unit="tables">1</extent>
<extent unit="references">79</extent>
</physicalDescription>
<abstract lang="en">After a break of 41 years, 2009 saw the first influenza pandemic of the 21st century caused by a triple-reassortant influenza A (H1N1) virus. The current estimated case fatality rate is lower than that of previous influenza pandemics, but this may change as the pandemic evolves. Illness frequently occurs in previously healthy, young adults with a wide range of clinical presentations. The majority of circulating pandemic viruses remain susceptible to neuraminidase inhibitors, although all strains are intrinsically resistant to the adamantanes. Monovalent vaccines against the pandemic strain are available in both live attenuated and inactivated forms. This review aims to summarise important virological, epidemiological and clinical aspects of the pandemic influenza A (H1N1) virus for physicians and other clinical personnel. Clin Chem Lab Med 2010;48:11–21.</abstract>
<subject><genre>Keywords</genre>
<topic>H1N1</topic>
<topic>influenza A virus</topic>
<topic>pandemic</topic>
<topic>review</topic>
<topic>swine flu</topic>
</subject>
<relatedItem type="host"><titleInfo><title>Clinical Chemistry and Laboratory Medicine</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<originInfo><publisher>Walter de Gruyter</publisher>
<dateIssued encoding="w3cdtf">2010-01-01</dateIssued>
<dateCreated encoding="w3cdtf">2009-12-22</dateCreated>
<copyrightDate encoding="w3cdtf">2010</copyrightDate>
</originInfo>
<identifier type="ISSN">1434-6621</identifier>
<identifier type="eISSN">1437-4331</identifier>
<identifier type="PublisherID">cclm</identifier>
<part><date>2010</date>
<detail type="volume"><caption>vol.</caption>
<number>48</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>11</start>
<end>21</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">D1BE8AC6F37BA8FCD15A07D02D0AF71100528FB1</identifier>
<identifier type="ark">ark:/67375/QT4-JJXDM453-F</identifier>
<identifier type="DOI">10.1515/CCLM.2010.023</identifier>
<identifier type="ArticleID">cclm.2010.023</identifier>
<identifier type="pdf">cclm.2010.023.pdf</identifier>
<accessCondition type="use and reproduction" contentType="copyright">©2010 by Walter de Gruyter Berlin New York</accessCondition>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-B4QPMMZB-D">degruyter-journals</recordContentSource>
<recordOrigin>Converted from  (version 1.2.10) to MODS version 3.6.</recordOrigin>
<recordCreationDate encoding="w3cdtf">2020-04-03</recordCreationDate>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/QT4-JJXDM453-F/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B60 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000B60 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:D1BE8AC6F37BA8FCD15A07D02D0AF71100528FB1
   |texte=   Pandemic influenza A (H1N1) 2009: the experience of the first six months
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Pandemic influenza A (H1N1) 2009: the experience of the first six months

Pandemic influenza A (H1N1) 2009: the experience of the first six months

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri